Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Haines

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Australian Journal of Primary Health|October 11, 2021
Evaluation of Australian prescription drug monitoring programs need a holistic approachSarah Haines, Pallavi Prathivadi
The American Journal of Bioethics : AJOB|May 29, 2019
Advancing Medicine Ethically: Important Considerations for Innovative PracticeSarah Haines, Michael Savic, Adrian Carter
Drug and Alcohol Review|May 31, 2023
Opioid-related policy changes: Experiences and perspectives from people who use opioids to manage non-cancer chronic painSarah Haines, Michael Savic, Suzanne Nielsen, et al.
The International Journal on Drug Policy|December 17, 2021
Key considerations for the implementation of clinically focused Prescription Drug Monitoring Programs to avoid unintended consequencesSarah Haines, Michael Savic, Suzanne Nielsen, et al.
Drug and Alcohol Dependence|October 2, 2021
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysisLouisa Picco, Tina Lam, Sarah Haines, et al.
The International Journal on Drug Policy|September 6, 2022
Patient experiences of prescription drug monitoring programs: a qualitative analysis from an Australian pharmaceutical helplineSarah Haines, Ashley Lam, Michael Savic, et al.
The Medical Journal of Australia|May 22, 2020
Unintended consequences of using real time prescription monitoring systemsSarah Haines, Michael Savic, Louisa Picco, et al.
International Journal of MS Care|September 6, 2021
Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical PracticeSarah Haines, Ernest Butler, Stephen Stuckey, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Australian Journal of Primary Health|October 11, 2021
Evaluation of Australian prescription drug monitoring programs need a holistic approachSarah Haines, Pallavi Prathivadi
The American Journal of Bioethics : AJOB|May 29, 2019
Advancing Medicine Ethically: Important Considerations for Innovative PracticeSarah Haines, Michael Savic, Adrian Carter
Drug and Alcohol Review|May 31, 2023
Opioid-related policy changes: Experiences and perspectives from people who use opioids to manage non-cancer chronic painSarah Haines, Michael Savic, Suzanne Nielsen, et al.
The International Journal on Drug Policy|December 17, 2021
Key considerations for the implementation of clinically focused Prescription Drug Monitoring Programs to avoid unintended consequencesSarah Haines, Michael Savic, Suzanne Nielsen, et al.
Drug and Alcohol Dependence|October 2, 2021
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysisLouisa Picco, Tina Lam, Sarah Haines, et al.
The International Journal on Drug Policy|September 6, 2022
Patient experiences of prescription drug monitoring programs: a qualitative analysis from an Australian pharmaceutical helplineSarah Haines, Ashley Lam, Michael Savic, et al.
The Medical Journal of Australia|May 22, 2020
Unintended consequences of using real time prescription monitoring systemsSarah Haines, Michael Savic, Louisa Picco, et al.
International Journal of MS Care|September 6, 2021
Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical PracticeSarah Haines, Ernest Butler, Stephen Stuckey, et al.
Pageof 1